tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ROIV Stock Latest News

3 Best Stocks to Buy Now, 7/19/2024, According to Top Analysts
Market News3 Best Stocks to Buy Now, 7/19/2024, According to Top Analysts
8d ago
GDEN
PRAX
Piper Sandler pharmaceuticals analyst holds an analyst/industry conference call
PremiumThe Fly
Piper Sandler pharmaceuticals analyst holds an analyst/industry conference call
16d ago
ROIV
Roivant Sciences price target raised to $22 from $20 at Piper Sandler
PremiumThe Fly
Roivant Sciences price target raised to $22 from $20 at Piper Sandler
16d ago
ROIV
Roivant Sciences reports Q4 EPS (19c), consensus (30c)
PremiumThe Fly
Roivant Sciences reports Q4 EPS (19c), consensus (30c)
2M ago
ROIV
ROIV Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ROIV Upcoming Earnings Report: What to Expect?
2M ago
ROIV
BuzzFeed (NASDAQ:BZFD) Skyrockets on Vivek Ramaswamy Revealing Stake
PremiumMarket NewsBuzzFeed (NASDAQ:BZFD) Skyrockets on Vivek Ramaswamy Revealing Stake
2M ago
ABUS
BZFD
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
PremiumPress Releases
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
2M ago
ROIV
Roivant Sciences put volume heavy and directionally bearish
PremiumThe Fly
Roivant Sciences put volume heavy and directionally bearish
3M ago
ROIV
Cantor Fitzgerald biopharma analyst holds analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biopharma analyst holds analyst/industry conference call
3M ago
ABUS
MRNA
Cantor Fitzgerald biopharma analyst holds analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biopharma analyst holds analyst/industry conference call
3M ago
ABUS
MRNA
Greenlight took long positions in HP, Penn Entertainment, Roivant Sciences in Q1
PremiumThe Fly
Greenlight took long positions in HP, Penn Entertainment, Roivant Sciences in Q1
3M ago
HPQ
PENN
Greenlight bought ‘small long position’ in Roivant during Q1
PremiumThe Fly
Greenlight bought ‘small long position’ in Roivant during Q1
3M ago
ROIV
Greenlight bought ‘small long position’ in Roivant during Q1
PremiumThe FlyGreenlight bought ‘small long position’ in Roivant during Q1
3M ago
ROIV
Cantor Fitzgerald biopharma analyst holds analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biopharma analyst holds analyst/industry conference call
3M ago
ABUS
MRNA
Moderna could owe $1B-$3B in royalties, says Jefferies
PremiumThe Fly
Moderna could owe $1B-$3B in royalties, says Jefferies
4M ago
ABUS
MRNA
Roivant, Arbutus higher after ruling on COVID patent order
PremiumThe Fly
Roivant, Arbutus higher after ruling on COVID patent order
4M ago
ABUS
MRNA
Jefferies sees Roivant rallying 5%-10% on today’s COVID patent order
PremiumThe Fly
Jefferies sees Roivant rallying 5%-10% on today’s COVID patent order
4M ago
PFE
ABUS
Roivant Sciences price target raised to $18 from $17 at H.C. Wainwright
PremiumThe Fly
Roivant Sciences price target raised to $18 from $17 at H.C. Wainwright
4M ago
ROIV
Roivant Sciences price target raised to $15 from $14 at Deutsche Bank
PremiumThe Fly
Roivant Sciences price target raised to $15 from $14 at Deutsche Bank
4M ago
ROIV
Roivant Sciences board approves of repurchase program up to $1.5B
PremiumThe FlyRoivant Sciences board approves of repurchase program up to $1.5B
4M ago
ROIV
Roivant Sciences announces NEPTUNE study met primary efficacy endpoint
PremiumThe Fly
Roivant Sciences announces NEPTUNE study met primary efficacy endpoint
4M ago
ROIV
Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million
PremiumPress Releases
Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million
4M ago
ROIV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >